During the past decade, JEM Research LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JEM Research LLC" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Impax Laboratories, LLC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JEM Research LLC" #1 collaborator was "Pfizer" with 3 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "JEM Research LLC" are "Alzheimer Disease" (6 trials), "Alzheimer's Disease" (6 trials), "Alzheimers Disease" (2 trials), "Osteoarthritis" (2 trials) and "Cognitive Dysfunction" (1 trials). Many other conditions were trialed in "JEM Research LLC" in a lesser frequency.

Most popular intervention types in "JEM Research LLC" are "Drug" (19 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Gantenerumab" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "JEM Research LLC" are 23 trials for "All" genders.

Currently, there are NaN active trials in "JEM Research LLC". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in JEM Research LLC, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in JEM Research LLC, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".